Literature DB >> 19449202

Wound healing and the immune response in swine treated with a hemostatic bandage composed of salmon thrombin and fibrinogen.

Stephen W Rothwell1, Evelyn Sawyer, Jennifer Dorsey, William S Flournoy, Timothy Settle, David Simpson, Gary Cadd, Paul Janmey, Charles White, Kathleen A Szabo.   

Abstract

We investigated the inflammatory response in pigs exposed to salmon fibrinogen/thrombin dressings. Animals were exposed to the material in 3 ways: (a) thrombin and fibrinogen were injected intravenously, (b) dual full-thickness skin lesions were surgically created on the dorsal aspect of the swine and treated with the fibrinogen/thrombin bandage and a commercial bandage or (c) a fibrinogen/thrombin bandage was inserted through an abdominal incision into the peritoneal cavity. Blood was collected twice weekly and animals were sacrificed at 7, 10 or 28 days. Animals in the 28-day dermal lesion group were given an injection of salmon fibrinogen/thrombin at the 10 day point to simulate a second bandage application. The immune response manifested itself as induction of germinal centers in mesenteric lymph nodes and in the white pulp of the spleen. Examination of the histology of the skin and organs showed a cellular inflammatory response with granulation tissue and signs of edema that resolved by the 28-day stage. Antibodies reactive to salmon and human thrombin and fibrinogen were detected, but fibrinogen levels and coagulation processes were not affected. In conclusion, animals treated with salmon fibrinogen/thrombin bandages demonstrated a smooth recovery course in terms of both tissue healing and the immune response without adverse effects from the exposure to the fish proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19449202      PMCID: PMC3118472          DOI: 10.1007/s10856-009-3769-2

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  24 in total

1.  Antihuman factor V antibodies after use of relatively pure bovine thrombin.

Authors:  Jeffrey H Lawson; Kellie A Lynn; Reed M Vanmatre; Taymon Domzalski; Keith F Klemp; Thomas L Ortel; Laura E Niklason; William Parker
Journal:  Ann Thorac Surg       Date:  2005-03       Impact factor: 4.330

2.  Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.

Authors:  S G Shelat; P Smith; J Ai; X L Zheng
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

Review 3.  Soft tissue wounds and principles of healing.

Authors:  Margaret K Strecker-McGraw; Thomas Russel Jones; David G Baer
Journal:  Emerg Med Clin North Am       Date:  2007-02       Impact factor: 2.264

Review 4.  Inflammation and wound healing.

Authors:  Tatiana M Oberyszyn
Journal:  Front Biosci       Date:  2007-05-01

5.  Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants.

Authors:  Sarah E Michaud; Louise Z Wang; Neha Korde; Robert Bucki; Paramjeet K Randhawa; Jennifer J Pastore; Hervé Falet; Karin Hoffmeister; Reet Kuuse; Raivo Uibo; Julia Herod; Evelyn Sawyer; Paul A Janmey
Journal:  Thromb Res       Date:  2002-09-01       Impact factor: 3.944

Review 6.  Rituximab in the treatment of adult acquired hemophilia A: a systematic review.

Authors:  Massimo Franchini
Journal:  Crit Rev Oncol Hematol       Date:  2007-01-19       Impact factor: 6.312

Review 7.  Anaphylactic reaction after artificial insemination.

Authors:  Marta Orta; Elena Ordoqui; Ascensión Aranzábal; Cristina Fernández; Borja Bartolomé; Maria Luisa Sanz
Journal:  Ann Allergy Asthma Immunol       Date:  2003-04       Impact factor: 6.347

8.  Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine.

Authors:  Anthony E Pusateri; Harold E Modrow; Richard A Harris; John B Holcomb; John R Hess; Robert H Mosebar; Thomas J Reid; James H Nelson; Cleon W Goodwin; Glenn M Fitzpatrick; Albert T McManus; David T Zolock; Jill L Sondeen; Rhonda L Cornum; Raul S Martinez
Journal:  J Trauma       Date:  2003-09

9.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004.

Authors:  John B Holcomb; Neil R McMullin; Lisa Pearse; Jim Caruso; Charles E Wade; Lynne Oetjen-Gerdes; Howard R Champion; Mimi Lawnick; Warner Farr; Sam Rodriguez; Frank K Butler
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more
  6 in total

1.  The potential for salmon fibrin and thrombin to mitigate pain subsequent to cervical nerve root injury.

Authors:  Christine L Weisshaar; Jessamine P Winer; Benjamin B Guarino; Paul A Janmey; Beth A Winkelstein
Journal:  Biomaterials       Date:  2011-09-22       Impact factor: 12.479

2.  The long term immunological response of swine after two exposures to a salmon thrombin and fibrinogen hemostatic bandage.

Authors:  Stephen W Rothwell; Timothy Settle; Shannon Wallace; Jennifer Dorsey; David Simpson; James R Bowman; Paul Janmey; Evelyn Sawyer
Journal:  Biologicals       Date:  2010-08-11       Impact factor: 1.856

3.  Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation.

Authors:  Kelli G Sharp; Amanda R Dickson; Steve A Marchenko; Kelly M Yee; Pauline N Emery; Ivo Laidmåe; Raivo Uibo; Evelyn S Sawyer; Oswald Steward; Lisa A Flanagan
Journal:  Exp Neurol       Date:  2012-03-05       Impact factor: 5.330

Review 4.  Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review.

Authors:  Atul A Chaudhari; Komal Vig; Dieudonné Radé Baganizi; Rajnish Sahu; Saurabh Dixit; Vida Dennis; Shree Ram Singh; Shreekumar R Pillai
Journal:  Int J Mol Sci       Date:  2016-11-25       Impact factor: 5.923

5.  Autologous fibrin sealant application in cardiac surgery - a single-centre observational study.

Authors:  Radosław Jarząbek; Krzysztof Greberski; Paweł Bugajski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-07-05

6.  Comparison of Topical Hemostatic Agents in a Swine Model of Extremity Arterial Hemorrhage: BloodSTOP iX Battle Matrix vs. QuikClot Combat Gauze.

Authors:  Huixi Li; Lin Wang; Amjad Alwaal; Yung-Chin Lee; Amanda Reed-Maldonado; Taylor A Spangler; Lia Banie; Reginald B O'Hara; Guiting Lin
Journal:  Int J Mol Sci       Date:  2016-04-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.